1. Home
  2. Labeler Index
  3. Blistex Inc.
  4. NDC Product Code: 10157-2126 Tucks Triple Relief Hemorrhoidal

NDC 10157-2126 Tucks Triple Relief Hemorrhoidal

White Petrolatum,Glycerin,Pramoxine Hydrochloride,And Phenylephrine Hydrochloride Cream - View Dosage, Usage, Ingredients, Routes, UNII

Table of Contents

  1. Product Information
  2. Product Packages
  3. What is NDC 10157-2126?
  4. Tucks Triple Relief Hemorrhoidal Uses
  5. Active Ingredients
  6. Active Ingredients UNII Codes
  7. Inactive Ingredients UNII Codes
  8. NDC to RxNorm Crosswalk
  9. Pharmacologic Classes

Product Information

Get all the details for National Drug Code (NDC) 10157-2126 in one place. This page breaks down everything you need to know about the NDC, including proprietary name, active and inactive substances, package configurations, billing units, labeler information, and routes of administration. It also includes enhanced data such as HCPCS codes, FDA product labels with images, UNIIs, and RxNorm cross-references. Whether you're a healthcare professional verifying drug data or a consumer researching medication, this NDC page helps you make informed, accurate decisions.

NDC Product Code:
10157-2126
Proprietary Name:
Tucks Triple Relief Hemorrhoidal
Non-Proprietary Name: [1]
White Petrolatum, Glycerin, Pramoxine Hydrochloride, And Phenylephrine Hydrochloride
Substance Name: [2]
Glycerin; Phenylephrine Hydrochloride; Pramoxine Hydrochloride; White Petrolatum
NDC Directory Status:
Human Otc Drug
Product Type: [3]
ACTIVE PRODUCT INCLUDED in the NDC Directory
Dosage Form:
Cream - An emulsion, semisolid3 dosage form, usually containing > 20% water and volatiles5 and/or < 50% hydrocarbons, waxes, or polyols as the vehicle. This dosage form is generally for external application to the skin or mucous membranes.
Administration Route(s): [4]
Topical - Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL.
Labeler Name: [5]
Blistex Inc.
Labeler Code:
10157
Product Label ID:
bf892e90-2d9b-4fa0-8ee4-8a2736be6c30
FDA Application Number: [6]
M015
Marketing Category: [8]
OTC MONOGRAPH DRUG -
Start Marketing Date: [9]
01-06-2025
Listing Expiration Date: [11]
12-31-2026
Exclude Flag: [12]
N
Code Navigator:

Code Structure Chart

Product Details

What is NDC 10157-2126?

The NDC code 10157-2126 is assigned by the FDA to the product Tucks Triple Relief Hemorrhoidal which is a human over the counter drug product labeled by Blistex Inc.. The generic name of Tucks Triple Relief Hemorrhoidal is white petrolatum, glycerin, pramoxine hydrochloride, and phenylephrine hydrochloride. The product's dosage form is cream and is administered via topical form. The product is distributed in a single package with assigned NDC code 10157-2126-1 1 tube, with applicator in 1 carton / 26 g in 1 tube, with applicator. This page includes all the important details about this product, including active and inactive ingredients, pharmagologic classes, product uses and characteristics, UNII information and RxNorm crosswalk.

What are the uses for Tucks Triple Relief Hemorrhoidal?

Adults:when practical, clean the affected area with mild soap and warm water and rinse thoroughlygently dry by patting or blotting with toilet tissue or a soft cloth before application of this productwhen first opening the tube, remove foil seal. Do not use if foil seal is broken.apply externally or in the lower portion of the anal canal onlyapply externally to the affected area up to 4 times dailyfor application in the lower anal canal, remove cover from dispensing cap. Attach dispensing cap to tube. Lubricate dispensing cap well, then gently insert dispensing cap partially into the anus.thoroughly clean dispensing cap after each use and replace coverchildren under 12 years of age: ask a doctor

What are Tucks Triple Relief Hemorrhoidal Active Ingredients?

An active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.

Which are Tucks Triple Relief Hemorrhoidal UNII Codes?

The UNII codes for the active ingredients in this product are:

Which are Tucks Triple Relief Hemorrhoidal Inactive Ingredients UNII Codes?

The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:

What is the NDC to RxNorm Crosswalk for Tucks Triple Relief Hemorrhoidal?

RxNorm is a normalized naming system for generic and branded drugs that assigns unique concept identifier(s) known as RxCUIs to NDC products.The NDC to RxNorm Crosswalk for this produdct indicates multiple concept unique identifiers (RXCUIs) are associated with this product:
  • RxCUI: 2701523 - glycerin 15 % / phenylephrine hydrochloride 0.25 % / pramoxine hydrochloride 1 % / white petrolatum 16 % Rectal Cream
  • RxCUI: 2701523 - glycerin 150 MG/ML / petrolatum 160 MG/ML / phenylephrine hydrochloride 2.5 MG/ML / pramoxine hydrochloride 10 MG/ML Rectal Cream

Which are the Pharmacologic Classes for Tucks Triple Relief Hemorrhoidal?

* Please review the disclaimer below.

Product Footnotes

[1] What is the Non-Proprietary Name? - The non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.

[2] What is the Substance Name? - An active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.

[3] What kind of product is this? - Indicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.

[4] What are the Administration Routes? - The translation of the route code submitted by the firm, indicating route of administration.

[5] What is the Labeler Name? - Name of Company corresponding to the labeler code segment of the Product NDC.

[6] What is the FDA Application Number? - This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null.

[8] What is the Marketing Category? - Product types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.

[9] What is the Start Marketing Date? - This is the date that the labeler indicates was the start of its marketing of the drug product.

[11] What is the Listing Expiration Date? - This is the date when the listing record will expire if not updated or certified by the product labeler.

[12] What is the NDC Exclude Flag? - This field indicates whether the product has been removed/excluded from the NDC Directory for failure to respond to FDA"s requests for correction to deficient or non-compliant submissions, or because the listing certification is expired, or because the listing data was inactivated by FDA, or because it was discontinued by the labeler. Possible values in this field are: "D", "E", "I", "N", "U".